RETACRIT (epoetin alfa-epbx) injection is a sterile, clear, and colorless solution in single-dose and multiple-dose vials available as:
| Unit of Sale | Strength | Each Single Unit of Use |
|---|---|---|
NDC 0069-1305-10 | 2,000 Units/mL | NDC 0069-1305-01 |
NDC 0069-1306-10 | 3,000 Units/mL | NDC 0069-1306-01 |
NDC 0069-1307-10 | 4,000 Units/mL | NDC 0069-1307-01 |
NDC 0069-1308-10 | 10,000 Units/mL | NDC 0069-1308-01 |
NDC 0069-1309-10 | 40,000 Units/mL | NDC 0069-1309-01 |
NDC 0069-1309-04 | 40,000 Units/mL | NDC 0069-1309-01 |
NDC 0069-1318-10 | 20,000 Units/2 mL | NDC 0069-1318-01 |
NDC 0069-1318-04 | 20,000 Units/2 mL | NDC 0069-1318-01 |
NDC 0069-1311-10 | 20,000 Units/mL | NDC 0069-1311-01 |
NDC 0069-1311-04 | 20,000 Units/mL | NDC 0069-1311-01 |
Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. When exposed to freezing temperatures, the green area of the freeze strip indicator in the carton of the multiple-dose vials will show signs of cloudy or white discoloration.
Do not shake. Do not use RETACRIT that has been shaken or frozen or if the green area of the freeze strip indicator is cloudy or white.
Store RETACRIT vials in the original carton until use to protect from light.
The vial stopper used for RETACRIT is not made with natural rubber latex.
RETACRIT (epoetin alfa-epbx) injection is a sterile, clear, and colorless solution in single-dose and multiple-dose vials available as:
| Unit of Sale | Strength | Each Single Unit of Use |
|---|---|---|
NDC 0069-1305-10 | 2,000 Units/mL | NDC 0069-1305-01 |
NDC 0069-1306-10 | 3,000 Units/mL | NDC 0069-1306-01 |
NDC 0069-1307-10 | 4,000 Units/mL | NDC 0069-1307-01 |
NDC 0069-1308-10 | 10,000 Units/mL | NDC 0069-1308-01 |
NDC 0069-1309-10 | 40,000 Units/mL | NDC 0069-1309-01 |
NDC 0069-1309-04 | 40,000 Units/mL | NDC 0069-1309-01 |
NDC 0069-1318-10 | 20,000 Units/2 mL | NDC 0069-1318-01 |
NDC 0069-1318-04 | 20,000 Units/2 mL | NDC 0069-1318-01 |
NDC 0069-1311-10 | 20,000 Units/mL | NDC 0069-1311-01 |
NDC 0069-1311-04 | 20,000 Units/mL | NDC 0069-1311-01 |
Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. When exposed to freezing temperatures, the green area of the freeze strip indicator in the carton of the multiple-dose vials will show signs of cloudy or white discoloration.
Do not shake. Do not use RETACRIT that has been shaken or frozen or if the green area of the freeze strip indicator is cloudy or white.
Store RETACRIT vials in the original carton until use to protect from light.
The vial stopper used for RETACRIT is not made with natural rubber latex.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.